267
Views
34
CrossRef citations to date
0
Altmetric
Reviews

Strategies for the discovery of therapeutic aptamers

, & , PhD (Deputy Director and James T. Willerson Distinguished Chair)
Pages 75-87 | Published online: 24 Nov 2010

Bibliography

  • Paul SM, Mytelka DS, Dunwiddie CT, How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010;9:203-14
  • Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-10
  • Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346:818-22
  • Bassett SE, Fennewald SM, King DJ, Combinatorial selection and edited combinatorial selection of phosphorothioate aptamers targeting human nuclear factor-kappaB RelA/p50 and RelA/RelA. Biochemistry 2004;43:9105-15
  • King DJ, Ventura DA, Brasier AR, Novel combinatorial selection of phosphorothioate oligonucleotide aptamers. Biochemistry 1998;37:16489-93
  • Stoltenburg R, Reinemann C, Strehlitz B. SELEX–a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 2007;24:381-403
  • Osborne SE, Ellington AD. Nucleic acid selection and the challenge of combinatorial chemistry. Chem Rev 1997;97:349-70
  • Uphoff KW, Bell SD, Ellington AD. In vitro selection of aptamers: the dearth of pure reason. Curr Opin Struct Biol 1996;6:281-8
  • Engelhardt J, Gorenstein DG, Luxon BA, inventors. Process and apparatus for combinatorial synthesis. US7576037; 2009
  • Bouchard PR, Hutabarat RM, Thompson KM. Discovery and development of therapeutic aptamers. Annu Rev Pharmacol Toxicol 2010;50:237-57
  • Keefe AD, Pai S, Ellington A. Aptamers as therapeutics. Nat Rev Drug Discov 2010;9:537-50
  • Osborne SE, Matsumura I, Ellington AD. Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr Opin Chem Biol 1997;1:5-9
  • Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999;45:1628-50
  • Rusconi CP, Scardino E, Layzer J, RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 2002;419:90-4
  • Lee JF, Hesselberth JR, Meyers LA, Aptamer database. Nucleic Acids Res 2004;32:D95-100
  • Pan W, Xin P, Patrick S, Primer-free aptamer selection using a random DNA library. J Vis Exp 2010;5(41). Doi: 10.3791/2039
  • Marshall KA, Ellington AD. In vitro selection of RNA aptamers. Methods Enzymol 2000;318:193-214
  • Eulberg D, Buchner K, Maasch C, Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res 2005;33:e45
  • Cox JC, Hayhurst A, Hesselberth J, Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res 2002;30:e108
  • Cox JC, Rajendran M, Riedel T, Automated acquisition of aptamer sequences. Comb Chem High Throughput Screen 2002;5:289-99
  • Cox JC, Ellington AD. Automated selection of anti-protein aptamers. Bioorg Med Chem 2001;9:2525-31
  • Sooter LJ, Riedel T, Davidson EA, Toward automated nucleic acid enzyme selection. Biol Chem 2001;382:1327-34
  • Kang J, Lee MS, Copland JA III, Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein. Bioorg Med Chem Lett 2008;18:1835-9
  • Kang J, Lee MS, Watowich SJ, Combinatorial selection of a RNA thioaptamer that binds to Venezuelan equine encephalitis virus capsid protein. FEBS Lett 2007;581:2497-502
  • Somasunderam A, Ferguson MR, Rojo DR, Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase. Biochemistry 2005;44:10388-95
  • King DJ, Bassett SE, Li X, Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50. Biochemistry 2002;41:9696-706
  • Andreola ML, Calmels C, Michel J, Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides. Eur J Biochem 2000;267:5032-40
  • Jhaveri S, Olwin B, Ellington AD. In vitro selection of phosphorothiolated aptamers. Bioorg Med Chem Lett 1998;8:2285-90
  • King DJ, Safar JG, Legname G, Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites. J Mol Biol 2007;369:1001-14
  • Hicke BJ, Marion C, Chang YF, Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem 2001;276:48644-54
  • Lupold SE, Hicke BJ, Lin Y, Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 2002;62:4029-33
  • Cerchia L, D'Alessio A, Amabile G, An autocrine loop involving ret and glial cell-derived neurotrophic factor mediates retinoic acid-induced neuroblastoma cell differentiation. Mol Cancer Res 2006;4:481-8
  • Burmeister PE, Lewis SD, Silva RF, Direct in vitro selection of a 2′-O-methyl aptamer to VEGF. Chem Biol 2005;12:25-33
  • Smith CJ, Steitz TA. Sno storm in the nucleolus: new roles for myriad small RNPs. Cell 1997;89:669-72
  • Haller AA, Sarnow P. In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci USA 1997;94:8521-6
  • Shangguan D, Li Y, Tang Z, Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 2006;103:11838-43
  • Ohuchi SP, Ohtsu T, Nakamura Y. A novel method to generate aptamers against recombinant targets displayed on the cell surface. Nucleic Acids Symp Ser 2005;49:351-2
  • Blank M, Weinschenk T, Priemer M, Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J Biol Chem 2001;276:16464-8
  • Geiger A, Burgstaller P, von der Eltz H, RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res 1996;24:1029-36
  • Jenison RD, Gill SC, Pardi A, High-resolution molecular discrimination by RNA. Science 1994;263:1425-9
  • Yang X, Gorenstein DG. Progress in thioaptamer development. Curr Drug Targets 2004;5:705-15
  • Morris KN, Jensen KB, Julin CM, High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci USA 1998;95:2902-7
  • Ulrich H, Ippolito JE, Pagan OR, In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 1998;95:14051-6
  • Ulrich H, Magdesian MH, Alves MJ, In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem 2002;277:20756-62
  • Homann M, Goringer HU. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res 1999;27:2006-14
  • Li N, Ebright JN, Stovall GM, Technical and biological issues relevant to cell typing with aptamers. J Proteome Res 2009;8:2438-48
  • Shamah SM, Healy JM, Cload ST. Complex target SELEX. Acc Chem Res 2008;41:130-8
  • Guo KT, Ziemer G, Paul A, CELL-SELEX: novel perspectives of aptamer-based therapeutics. Int J Mol Sci 2008;9:668-78
  • Fang X, Tan W. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res 2010;43:48-57
  • Mi J, Liu Y, Rabbani ZN, In vivo selection of tumor-targeting RNA motifs. Nat Chem Biol 2010;6:22-4
  • Smith D, Kirschenheuter GP, Charlton J, In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. Chem Biol 1995;2:741-50
  • Charlton J, Kirschenheuter GP, Smith D. Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library. Biochemistry 1997;36:3018-26
  • Radrizzani M, Broccardo M, Gonzalez Solveyra C, Oligobodies: bench made synthetic antibodies. Medicina 1999;59:753-8
  • Jensen KB, Atkinson BL, Willis MC, Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci USA 1995;92:12220-4
  • Kopylov AM, Spiridonova VA. Combinatorial chemistry of nucleic acids: SELEX. Mol Biol 2000;34:1097-113
  • Brody EN, Willis MC, Smith JD, The use of aptamers in large arrays for molecular diagnostics. Mol Diagn 1999;4:381-8
  • Golden MC, Collins BD, Willis MC, Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. J Biotechnol 2000;81:167-78
  • Wlotzka B, Leva S, Eschgfaller B, In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class. Proc Natl Acad Sci USA 2002;99:8898-902
  • Schumacher TN, Mayr LM, Minor DL Jr, Identification of D-peptide ligands through mirror-image phage display. Science 1996;271:1854-7
  • Williams KP, Liu XH, Schumacher TN, Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci USA 1997;94:11285-90
  • Vater A, Jarosch F, Buchner K, Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. Nucleic Acids Res 2003;31:e130
  • Vater A, Klussmann S. Toward third-generation aptamers: spiegelmers and their therapeutic prospects. Curr Opin Drug Discov Devel 2003;6:253-61
  • White RR, Sullenger BA, Rusconi CP. Developing aptamers into therapeutics. J Clin Invest 2000;106:929-34
  • White R, Rusconi C, Scardino E, Generation of species cross-reactive aptamers using “toggle” SELEX. Mol Ther 2001;4:567-73
  • Mendonsa SD, Bowser MT. In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. J Am Chem Soc 2005;127:9382-3
  • Mendonsa SD, Bowser MT. In vitro evolution of functional DNA using capillary electrophoresis. J Am Chem Soc 2004;126:20-1
  • Berezovski M, Krylov SN. Using nonequilibrium capillary electrophoresis of equilibrium mixtures for the determination of temperature in capillary electrophoresis. Anal Chem 2004;76:7114-17
  • Mendonsa SD, Bowser MT. In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal Chem 2004;76:5387-92
  • Mosing RK, Mendonsa SD, Bowser MT. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 2005;77:6107-12
  • Tang J, Xie J, Shao J, The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods. Electrophoresis 2006;27:1303-11
  • Berezovski M, Drabovich A, Krylova SM, Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. J Am Chem Soc 2005;127:3165-71
  • Drabovich A, Berezovski M, Krylov SN. Selection of smart aptamers by equilibrium capillary electrophoresis of equilibrium mixtures (ECEEM). J Am Chem Soc 2005;127:11224-5
  • Berezovski MV, Musheev MU, Drabovich AP, Non-SELEX: selection of aptamers without intermediate amplification of candidate oligonucleotides. Nat Protocols 2006;1:1359-69
  • Bruno JG, Kiel JL. Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods. Biotechniques 2002;32:178-80, 82-3
  • Bruno JG, Kiel JL. In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection. Biosens Bioelectron 1999;14:457-64
  • Lou X, Qian J, Xiao Y, Micromagnetic selection of aptamers in microfluidic channels. Proc Natl Acad Sci USA 2009;106:2989-94
  • Qian J, Lou X, Zhang Y, Generation of highly specific aptamers via micromagnetic selection. Anal Chem 2009;81:5490-5
  • Miyachi Y, Shimizu N, Ogino C, Selection of DNA aptamers using atomic force microscopy. Nucleic Acids Res 2010;38:e21
  • Peng L, Stephens BJ, Bonin K, A combined atomic force/fluorescence microscopy technique to select aptamers in a single cycle from a small pool of random oligonucleotides. Microsc Res Tech 2007;70:372-81
  • Smith EA, Corn RM. Surface plasmon Rpesonance imaging as a tool to monitor biomolecular interactions in an array based format. Appl Spectrosc 2003;57:320A-332A
  • Li Y, Lee HJ, Corn RM. Fabrication and characterization of RNA aptamer microarrays for the study of protein-aptamer interactions with SPR imaging. Nucleic Acids Res 2006;34:6416-24
  • Misono TS, Kumar PK. Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal Biochem 2005;342:312-17
  • Collett JR, Cho EJ, Lee JF, Functional RNA microarrays for high-throughput screening of antiprotein aptamers. Anal Biochem 2005;338:113-23
  • Collett JR, Cho EJ, Ellington AD. Production and processing of aptamer microarrays. Methods 2005;37:4-15
  • Asai R, Nishimura SI, Aita T, In vitro selection of DNA aptamers on chips using a method for generating point mutations. Anal Lett 2004;37:645-56
  • Chushak Y, Stone MO. In silico selection of RNA aptamers. Nucleic Acids Res 2009;37:e87
  • Katilius E, Flores C, Woodbury NW. Exploring the sequence space of a DNA aptamer using microarrays. Nucleic Acids Res 2007;35:7626-35
  • Yang X, Fennewald S, Luxon BA, Aptamers containing thymidine 3′-O-phosphorodithioates: synthesis and binding to nuclear factor-kappaB. Bioorg Med Chem Lett 1999;9:3357-62
  • Ludwig J, Eckstein F. Synthesis of nucleoside 5′-O-(1,3-dithiotripgosphates) and 5′-O-(1,1,-Dithiotriphosphates). J Org Chem 1991;56:1777-83
  • Yang X, Bassett SE, Li X, Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Res 2002;30:e132
  • Yang X, Li X, Prow TW, Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. Nucleic Acids Res 2003;31:e54
  • Yang X, Wang H, Beasley DW, Selection of thioaptamers for diagnostics and therapeutics. Ann NY Acad Sci 2006;1082:116-19
  • Meyers LA, Lee JF, Cowperthwaite M, The robustness of naturally and artificially selected nucleic acid secondary structures. J Mol Evol 2004;58:681-91
  • Tsuji S, Hirabayashi N, Kato S, Effective isolation of RNA aptamer through suppression of PCR bias. Biochem Biophys Res Commun 2009;386:223-6
  • Mairal T, Ozalp VC, Lozano Sanchez P, Aptamers: molecular tools for analytical applications. Anal Bioanal Chem 2008;390:989-1007
  • Blank M, Blind M. Aptamers as tools for target validation. Curr Opin Chem Biol 2005;9:336-42
  • Burgstaller P, Girod A, Blind M. Aptamers as tools for target prioritization and lead identification. Drug Discov Today 2002;7:1221-8
  • Cox JC, Rudolph P, Ellington AD. Automated RNA selection. Biotechnol Prog 1998;14:845-50
  • Drolet DW, Moon-McDermott L, Romig TS. An enzyme-linked oligonucleotide assay. Nat Biotechnol 1996;14:1021-5
  • Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu Rev Med 2005;56:555-83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.